Pfizer Inc. (PFE)
28.56
+0.10
(+0.37%)
USD |
NYSE |
Sep 01, 16:00
28.55
-0.02
(-0.05%)
After-Hours: 18:49
Pfizer Research and Development Expense (Annual) : 10.25B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 10.25B |
| December 31, 2024 | 10.74B |
| December 31, 2023 | 10.58B |
| December 31, 2022 | 11.43B |
| December 31, 2021 | 13.83B |
| December 31, 2020 | 9.395B |
| December 31, 2019 | 8.364B |
| December 31, 2018 | 7.967B |
| December 31, 2017 | 7.645B |
| December 31, 2016 | 7.84B |
| December 31, 2015 | 7.671B |
| December 31, 2014 | 8.31B |
| December 31, 2013 | 6.551B |
| December 31, 2012 | 6.955B |
| December 31, 2011 | 8.004B |
| December 31, 2010 | 9.358B |
| December 31, 2009 | 7.754B |
| December 31, 2008 | 7.512B |
| December 31, 2007 | 7.573B |
| December 31, 2006 | 7.423B |
| December 31, 2005 | 7.206B |
| December 31, 2004 | 7.62B |
| December 31, 2003 | 7.07B |
| Date | Value |
|---|---|
| December 31, 2002 | 5.176B |
| December 31, 2001 | 4.847B |
| December 31, 2000 | 4.435B |
| December 31, 1999 | 2.776B |
| December 31, 1998 | 2.279B |
| December 31, 1997 | 1.928B |
| December 31, 1996 | 1.684B |
| December 31, 1995 | 1.442B |
| December 31, 1994 | 1.139B |
| December 31, 1993 | 974.40M |
| December 31, 1992 | 863.20M |
| December 31, 1991 | 756.80M |
| December 31, 1990 | 640.10M |
| December 31, 1989 | 531.20M |
| December 31, 1988 | 472.50M |
| December 31, 1987 | 401.00M |
| December 31, 1986 | 335.50M |
| December 31, 1985 | 286.70M |
| December 31, 1984 | 252.30M |
| December 31, 1983 | 227.20M |
| December 31, 1982 | 197.20M |
| December 31, 1981 | 176.90M |
| December 31, 1980 | 159.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| Bristol Myers Squibb Co. | 9.492B |
| Viatris, Inc. | 952.50M |